Nanjing King-friend Biochemical Hits Day High with 3.11% Surge

Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. has experienced a notable uptick today, with the stock rising by 3.11% as of July 1, 2026. The stock reached an intraday high of CNY 7.31, marking a significant moment in its trading activity. In terms of performance metrics, Nanjing King-friend has shown a 1-day performance that outpaces the China Shanghai Composite, which recorded a modest gain of 0.44%. Over the past week, the stock has increased by 2.39%, again surpassing the benchmark's 0.04% rise. However, the longer-term outlook reveals challenges, with a 1-month decline of 11.96% and a year-to-date drop of 19.27%. Despite these fluctuations, the company maintains a market capitalization of CNY 12,990 million and a price-to-earnings ratio of 25.00. The stock's dividend yield stands at 1.24%, reflecting its commitment to returning value to shareholders. Overall, while today's performance is positive, the company continues to navigate a complex financial landscape.